Table of Content



1 Relevant Concepts of Temozolomide
1.1 Indications for Temozolomide
1.2 Development of Temozolomide in China
1.3 Governmental Approval of Temozolomide in China
1.4 The Impact of COVID-19 on Temozolomide sales in China


2 Sales of Temozolomide in China, 2016-2020
2.1 Sales Value of Temozolomide
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Temozolomide
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Temozolomide by Dosage Form in China, 2016-2020
2.3.1 Injection
2.3.2 Analysis of Other Dosage Forms


3 Analysis of Major Temozolomide Manufacturers in China in 2020
3.1 Analysis of Market Share of Major Temozolomide Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Merck Sharp & Dohme Ltd
3.2.1 Enterprise Profile
3.2.2 Sales of TEMODAL (Merck Sharp & Dohme Ltd’s Temozolomide) in China
3.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Diqing (Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.’s Temozolomide) in China
3.4 Beijing Shuanglu Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Jiaoning (Beijing Shuanglu Pharmaceutical Co., Ltd. ’s Temozolomide) in China
3.5 Schering-Plough Canada
3.5.1 Enterprise Profile
3.5.2 Sales of TEMODAL (Schering-Plough Canada’s Temozolomide) in China
3.6 Jiangsu Hengrui Medicine Company Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Jiangsu Hengrui Medicine Company Ltd.’s Temozolomide in China


4 Prices of Temozolomide for Different Manufacturers in China, 2020-2021
4.1 Merck Sharp & Dohme Ltd (TEMODAL)
4.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. (Diqing)
4.3 Beijing Shuanglu Pharmaceutical Co., Ltd. (Jiaoning)
4.4 Schering-Plough Canada (TEMODAL)
4.5 Jiangsu Hengrui Medicine Company Ltd.


5 Prospect of Chinese Temozolomide drug Market, 2021-2025
5.1 Influential Factors of Chinese Temozolomide Market Development
5.1.1 The Impact of COVID-19 on Chinese Temozolomide Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information About Temozolomide Injection Registration in China
Chart Sales Value of Temozolomide Injection over the World
Chart Sales Value of Temozolomide Injection in China, 2016-2020
Chart Sales Value of Temozolomide Injection in China by Region, 2016-2020
Chart Sales Volume of Temozolomide Injection in China, 2016-2020
Chart Sales Volume of Temozolomide Injection in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Temozolomide Manufacturers in China, 2016-2020
Chart Sales Value and Volume of TEMODAL (Merck Sharp & Dohme Ltd’s Temozolomide) in China, 2016-2020
Chart Sales Value and Volume of Diqing in China, 2016-2020
Chart Sales Value and Volume of Jiaoning in China, 2016-2020
Chart Sales Value and Volume of TEMODAL (Schering-Plough Canada’s Temozolomide) in China, 2016-2020
Chart Sales Value and Volume of Jiangsu Hengrui Medicine Company Ltd.’s Temozolomide in China, 2016-2020
Chart Referential Prices of TEMODAL (Merck Sharp & Dohme Ltd’s Temozolomide) in China, 2020-2021
Chart Referential Prices of Diqing in China, 2020-2021
Chart Referential Prices of Jiaoning in China, 2020-2021
Chart Referential Prices of TEMODAL (Schering-Plough Canada’s Temozolomide) in China, 2020-2021
Chart Referential Prices of Jiangsu Hengrui Medicine Company Ltd.’s Temozolomide in China, 2020-2021
Chart Forecast on Sales Value of Temozolomide in China, 2021-2025
Chart Forecast on Sales Volume of Temozolomide in China, 2021-2025



List of Tables

Table of Contents


1 Relevant Concepts of Temozolomide



  • 1.1 Indications for Temozolomide

  • 1.2 Development of Temozolomide in China

  • 1.3 Governmental Approval of Temozolomide in China

  • 1.4 The Impact of COVID-19 on Temozolomide sales in China


 


2 Sales of Temozolomide in China, 2016-2020   



  • 2.1 Sales Value of Temozolomide

  • 2.1.1 Overall Sales Value

  • 2.1.2 Sales Value by Region 

  • 2.2 Sales Volume of Temozolomide     

  • 2.2.1 Overall Sales Volume  

  • 2.2.2 Sales Volume by Region     

  • 2.3 Sales of Temozolomide by Dosage Form in China, 2016-2020    

  • 2.3.1 Injection

  • 2.3.2 Analysis of Other Dosage Forms


      


3 Analysis of Major Temozolomide Manufacturers in China in 2020  



  • 3.1 Analysis of Market Share of Major Temozolomide Manufacturers

  • 3.1.1 Investigation on Market Share by Sales Value    

  • 3.1.2 Investigation on Market Share by Sales volume 

  • 3.2 Merck Sharp & Dohme Ltd    

  • 3.2.1 Enterprise Profile 

  • 3.2.2 Sales of TEMODAL (Merck Sharp & Dohme Ltd’s Temozolomide) in China  

  • 3.3  Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.

  • 3.3.1 Enterprise Profile 

  • 3.3.2 Sales of Diqing (Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.’s Temozolomide) in China

  • 3.4 Beijing Shuanglu Pharmaceutical Co., Ltd.  

  • 3.4.1 Enterprise Profile 

  • 3.4.2 Sales of Jiaoning (Beijing Shuanglu Pharmaceutical Co., Ltd. ’s Temozolomide) in China

  • 3.5 Schering-Plough Canada

  • 3.5.1 Enterprise Profile 

  • 3.5.2 Sales of TEMODAL (Schering-Plough Canada’s Temozolomide) in China

  • 3.6 Jiangsu Hengrui Medicine Company Ltd.

  • 3.6.1 Enterprise Profile 

  • 3.6.2 Sales of Jiangsu Hengrui Medicine Company Ltd.’s Temozolomide in China


 


4 Prices of Temozolomide for Different Manufacturers in China, 2020-2021



  • 4.1 Merck Sharp & Dohme Ltd (TEMODAL)

  • 4.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. (Diqing)

  • 4.3 Beijing Shuanglu Pharmaceutical Co., Ltd.  (Jiaoning)

  • 4.4 Schering-Plough Canada (TEMODAL)

  • 4.5 Jiangsu Hengrui Medicine Company Ltd.


 


5 Prospect of Chinese Temozolomide drug Market, 2021-2025



  • 5.1 Influential Factors of Chinese Temozolomide Market Development

  • 5.1.1 The Impact of COVID-19 on Chinese Temozolomide Market

  • 5.1.2 Market Drivers and Opportunities

  • 5.1.3 Market Threats and Challenges

  • 5.2 Forecast on Market Size 

  • 5.3 Forecast on Market Trend


 


List of Charts



  • Chart Patent Information About Temozolomide Injection Registration in China

  • Chart Sales Value of Temozolomide Injection over the World    

  • Chart Sales Value of Temozolomide Injection in China, 2016-2020   

  • Chart Sales Value of Temozolomide Injection in China by Region, 2016-2020

  • Chart Sales Volume of Temozolomide Injection in China, 2016-2020

  • Chart Sales Volume of Temozolomide Injection in China by Region, 2016-2020

  • Chart Market Share by Sales Value of Top Temozolomide Manufacturers in China, 2016-2020

  • Chart Sales Value and Volume of TEMODAL (Merck Sharp & Dohme Ltd’s Temozolomide) in China, 2016-2020 

  • Chart Sales Value and Volume of Diqing in China, 2016-2020

  • Chart Sales Value and Volume of Jiaoning in China, 2016-2020 

  • Chart Sales Value and Volume of TEMODAL (Schering-Plough Canada’s Temozolomide) in China, 2016-2020    

  • Chart Sales Value and Volume of Jiangsu Hengrui Medicine Company Ltd.’s Temozolomide in China, 2016-2020        

  • Chart Referential Prices of TEMODAL (Merck Sharp & Dohme Ltd’s Temozolomide) in China, 2020-2021

  • Chart Referential Prices of Diqing in China, 2020-2021      

  • Chart Referential Prices of Jiaoning in China, 2020-2021          

  • Chart Referential Prices of TEMODAL (Schering-Plough Canada’s Temozolomide) in China, 2020-2021      

  • Chart Referential Prices of Jiangsu Hengrui Medicine Company Ltd.’s Temozolomide in China, 2020-2021

  • Chart Forecast on Sales Value of Temozolomide in China, 2021-2025

  • Chart Forecast on Sales Volume of Temozolomide in China, 2021-2025